These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30815383)

  • 21. Caffeine versus theophylline for apnea in preterm infants.
    Henderson-Smart DJ; Steer PA
    Cochrane Database Syst Rev; 2010 Jan; (1):CD000273. PubMed ID: 20091506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeine controversies.
    Gentle SJ; Travers CP; Carlo WA
    Curr Opin Pediatr; 2018 Apr; 30(2):177-181. PubMed ID: 29346141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Caffeine versus Theophylline for apnea of prematurity.
    Zulqarnain A; Hussain M; Suleri KM; Ch ZA
    Pak J Med Sci; 2019; 35(1):113-116. PubMed ID: 30881407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discharging Preterm Infants Home on Caffeine, a Single Center Experience.
    Ma C; Broadbent D; Levin G; Panda S; Sambalingam D; Garcia N; Ruiz E; Singh AP
    Children (Basel); 2020 Aug; 7(9):. PubMed ID: 32872145
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of caffeine citrate on early pulmonary function in preterm infants with apnea].
    Yu M; Huang JH; Zhu R; Zhang XZ; Wu WY; Wen XH
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Mar; 18(3):206-10. PubMed ID: 26975815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-based methylxanthine use in the NICU.
    Spitzer AR
    Clin Perinatol; 2012 Mar; 39(1):137-48. PubMed ID: 22341542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001079. PubMed ID: 10796410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic methylxanthines for endotracheal extubation in preterm infants.
    Henderson-Smart DJ; Davis PG
    Cochrane Database Syst Rev; 2010 Dec; (12):CD000139. PubMed ID: 21154342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity.
    Lemyre B; Davis PG; De Paoli AG
    Cochrane Database Syst Rev; 2000; (3):CD002272. PubMed ID: 10908544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylxanthine treatment for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2001; (3):CD000140. PubMed ID: 11686952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylxanthine treatment for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000140. PubMed ID: 10796304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of caffeine on preterm infants' cerebral cortical activity: an observational study.
    Hassanein SM; Gad GI; Ismail RI; Diab M
    J Matern Fetal Neonatal Med; 2015; 28(17):2090-5. PubMed ID: 25330842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity.
    Lemyre B; Davis PG; de Paoli AG
    Cochrane Database Syst Rev; 2002; (1):CD002272. PubMed ID: 11869635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical associations of immature breathing in preterm infants: part 1-central apnea.
    Fairchild K; Mohr M; Paget-Brown A; Tabacaru C; Lake D; Delos J; Moorman JR; Kattwinkel J
    Pediatr Res; 2016 Jul; 80(1):21-7. PubMed ID: 26959485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
    Skouroliakou M; Bacopoulou F; Markantonis SL
    J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical effect of early or late administration of caffeine citrate in prevention and treatment of apnea in very low birth weight infants].
    Feng Y; Cheng R; Zhao L; Chen X; Mao XN; Qiu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Dec; 20(12):979-984. PubMed ID: 30572984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caffeine Treatment for Apnea of Prematurity and the Influence on Dose-Dependent Postnatal Weight Gain Observed Over 15 Years.
    Philip RK; Ismail A; Murphy B; Mirza A; Quinn C; Dunworth M
    J Caffeine Adenosine Res; 2018 Sep; 8(3):99-106. PubMed ID: 30250944
    [No Abstract]   [Full Text] [Related]  

  • 39. Transplacentally acquired caffeine and the occurrence of apnea, bradycardia, and periodic breathing in preterm infants: preliminary communication.
    McCulloch KM; Braun RJ; Simms PE; Evans MA; Kelly DH
    Pediatr Pulmonol; 1989; 7(2):66-70. PubMed ID: 2797922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of early caffeine treatment on the need for respirator therapy in preterm infants with respiratory distress syndrome].
    Wei QZ; Su P; Han JT; Zhang X; Duan YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Dec; 18(12):1227-1231. PubMed ID: 27974112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.